T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Kemp, Roslyn A ^a   Black, Michael A ^a   McCall, John ^a   Yoon, Han Seung ^a   Phillips, Vicky ^a   Anjomshoaa, Ahmad ^a,b   Reeve, Anthony E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CELL POPULATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; CD4+ T LYMPHOCYTE; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROGNOSIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR RECURRENCE;

AGED; CD4-POSITIVE T-LYMPHOCYTES; COLORECTAL NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPH NODES; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 80052025373     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-78     Document Type: Article

References (31)

1. Cancer. WHO, 2009 297
2. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ, Lancet 2007 370 2020 2029 10.1016/S0140-6736(07)61866-2 18083404 (Pubitemid 350236339)
3. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, et al. Ann Intern Med 1995 122 321 326 7847642
4. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. Gonen M, Schrag D, Weiser MR, J Clin Oncol 2009 27 6166 6171 10.1200/JCO.2009.23.7958 19901106
5. The number of analyzed lymph nodes-a prognostic factor in colorectal cancer. Edler D, Ohrling K, Hallstrom M, Karlberg M, Ragnhammar P, Acta oncologica (Stockholm, Sweden) 2007 46 975 981 10.1080/02841860701203537 (Pubitemid 47537177)
6. Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Bilchik A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M, Howard R, Elashoff D, Tyler J, Peoples GE, et al. Ann Surg 252 467 474 discussion 474-466
7. [DNA microarrays (DNA chips) used in molecular medical research]. Orntoft TF, Ugeskr Laeger 2003 165 786 790 12625118 (Pubitemid 36253813)
8. Slow proliferation as a biological feature of colorectal cancer metastasis. Anjomshoaa A, Nasri S, Humar B, McCall JL, Chatterjee A, Yoon HS, McNoe L, Black MA, Reeve AE, Br J Cancer 2009 101 822 828 10.1038/sj.bjc.6605229 19654572
9. Interferons, immunity and cancer immunoediting. Dunn GP, Koebel CM, Schreiber RD, Nat Rev Immunol 2006 6 836 848 10.1038/nri1961 17063185 (Pubitemid 44631652)
10. Effector memory T cells, early metastasis, and survival in colorectal cancer. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, et al. N Engl J Med 2005 353 2654 2666 10.1056/NEJMoa051424 16371631 (Pubitemid 41817714)
11. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H, Cancer Res 1998 58 3491 3494 9721846 (Pubitemid 28376536)
12. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, et al. Science 2006 313 1960 1964 10.1126/science.1129139 17008531 (Pubitemid 44498003)
13. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov N, Toro T, et al. Clin Cancer Res 2007 13 498 507 10.1158/1078-0432.CCR-05-2734 17255271 (Pubitemid 46225355)
14. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, George BD, Warren BF, Piris J, Roncador G, Fox SB, et al. Cancer Immun 2007 7 7 17388261
15. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM, et al. PLoS ONE 2006 1 129 10.1371/journal.pone.0000129 17205133
16. Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Yaqub S, Henjum K, Mahic M, Jahnsen FL, Aandahl EM, Bjornbeth BA, Tasken K, Cancer Immunol Immunother 2008 57 813 821 10.1007/s00262-007-0417-x 17962941 (Pubitemid 351660125)
17. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L, Int J Cancer 2010 126 2635 2643 19856313
18. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B, J Clin Oncol 2009 27 186 192 10.1200/JCO.2008.18.7229 19064967
19. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Menegaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J, Gut 2009 58 520 529 10.1136/gut.2008.158824 19022917
20. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP, PLoS medicine 2005 2 284 10.1371/journal.pmed.0020284 16124834 (Pubitemid 41382925)
21. FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions. Ahmadzadeh M, Felipe-Silva A, Heemskerk B, Powell DJ Jr, Wunderlich JR, Merino MJ, Rosenberg SA, Blood 2008 112 4953 4960 10.1182/blood-2008-06-163048 18820132
22. R: A language and environment for statistical computing. Team RDC, Viennna, Austria: R Foundation for Statistical Computing 2010
23. CD4 T-cell differentiation and inflammatory bowel disease. Zenewicz LA, Antov A, Flavell RA, Trends Mol Med 2009 15 199 207 10.1016/j.molmed.2009.03.002 19362058
24. Therapy with anti-TNFalpha antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Boschetti G, Nancey S, Sardi F, Roblin X, Flourie B, Kaiserlian D, Inflamm Bowel Dis 2011 17 160 170 10.1002/ibd.21308 20848510
25. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Ladoire S, Martin F, Ghiringhelli F, Cancer Immunol Immunother 2011 60 909 918 10.1007/s00262-011-1046-y 21644034
26. The tumor-draining lymph node as an immune-privileged site. Munn DH, Mellor AL, Immunol Rev 2006 213 146 158 10.1111/j.1600-065X.2006.00444.x 16972902 (Pubitemid 44401499)
27. Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. Tanaka H, Tanaka J, Kjaergaard J, Shu S, J Immunother 2002 25 207 217 10.1097/00002371-200205000- 00003 12000862 (Pubitemid 34533310)
28. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Deng L, Zhang H, Luan Y, Zhang J, Xing Q, Dong S, Wu X, Liu M, Wang S, Clin Cancer Res 2010 16 4105 4112 10.1158/1078-0432.CCR-10-1073 20682706
29. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Ohtani H, Cancer Immun 2007 7 4 17311363
30. Diagnostic use of the sentinel node in colon cancer. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, McCall JL, Dis Colon Rectum 2001 44 410 417 10.1007/BF02234742 11289289 (Pubitemid 32226332)
31. Plasticity of CD4(+) FoxP3(+) T cells. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA, Curr Opin Immunol 2009 21 281 285 10.1016/j.coi.2009.05.007 19500966